Amazon Receives Year-End Greetings From US FDA

Warning references consumer alerts FDA published in February and August about products agency officials purchased on Amazon.com and determined to contain undisclosed sildenafil or tadalafil, PDE-5 inhibitors approved for use in Rx drugs with an ED indication.

• Source: Shutterstock

The US Food and Drug Administration has warned Amazon.com about its distribution of products labeled as dietary supplements but containing undisclosed erectile dysfunction drugs 10 months after it began warning consumers about the products bought on the e-commerce giant's site. 

The agency on 26 December posted a warning letter the Center for Food Safety and Applied Nutrition Office of Compliance...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Policy & Regulation